NJ

Nishita Jarnalsingh Bhuttar

Active Director Director DIN 06628380
DIN 06628380 First appointment Sep 2013 Primary industry Information Technology
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Sep 2013
Shareholding value β€’β€’β€’β€’ Premium profile

About Nishita Jarnalsingh Bhuttar

Data last updated:

Nishita Jarnalsingh Bhuttar is a Director at Mediclix Technologies Private Limited (since 2013). The company operates in Information Technology.

DIN 06628380
Primary Designation Director
Industry Information Technology
First Appointment 28 Sep 2013
Oldest Company Age 13 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director28 Sep 20132013Active

Directorship timeline

Open interactive timeline →
Mediclix Technologies Private Limited
Premium access

Shareholding and investment profile for Nishita Jarnalsingh Bhuttar

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Nishita Jarnalsingh Bhuttar

Nishita Jarnalsingh Bhuttar currently holds 1 directorship: Mediclix Technologies Private Limited (Director, since 28 Sep 2013).

Nishita Jarnalsingh Bhuttar was first appointed on 28 Sep 2013 as Director at Mediclix Technologies Private Limited.

The current boards of Nishita Jarnalsingh Bhuttar's companies include Jarnalsingh Swaransingh Bhuttar (Mediclix Technologies Private Limited), Ravin Jarnalsingh Bhuttar (Mediclix Technologies Private Limited), Sharayu Bhuttar Jarnalsingh (Mediclix Technologies Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available